Sibylle Loibl
MD, PhD
Chair German Breast Group
👥Biography 个人简介
Sibylle Loibl chairs the German Breast Group and is a leading international breast cancer clinical trialist. She has led pivotal neoadjuvant and adjuvant trials including KATHERINE establishing T DM1 for residual disease after neoadjuvant therapy. Her work has shaped contemporary escalation strategies. She is among the most influential voices in breast oncology today.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Sibylle Loibl 的研究动态
Follow Sibylle Loibl's research updates
留下邮箱，当我们发布与 Sibylle Loibl（German Breast Group）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment